Improving diabetic patients’ adherence to treatment and prevention of cardiovascular disease (Office Guidelines Applied to Practice—IMPACT Study)—a cluster randomized controlled effectiveness trial

Improving diabetic patients’ adherence to treatment and prevention of cardiovascular disease (Office Guidelines Applied to Practice—IMPACT Study)—a cluster randomized controlled effectiveness trial

Abstract Background Despite nationwide improvements in cardiovascular disease (CVD) mortality and morbidity, CVD deaths in adults with type 2 diabetes (T2DM) are 2–4 times higher than among those without T2DM. A key contributor to these poor health outcomes is medication non-adherence. Twenty-one to...

Full description

Bibliographic Details
Main Authors: Adesuwa Olomu, Karen Kelly-Blake, William Hart-Davidson, Joseph Gardiner, Zhehui Luo, Michele Heisler, Margaret Holmes-Rovner
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Trials
Subjects:
Diabetes mellitus
Cardiovascular disease prevention
Medication adherence
Patient activation
mHealth intervention
Federally Qualified Health Care Centers
Online Access:https://doi.org/10.1186/s13063-022-06581-6

Internet

https://doi.org/10.1186/s13063-022-06581-6

Similar Items